Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Are Palantir CEO's Cocaine Comments A 'Projection?' Legendary Short Sellers Clap Back At Critiques, Flag Insider Trade Data

Published 14/03/2024, 17:24
© Reuters.  Are Palantir CEO's Cocaine Comments A 'Projection?' Legendary Short Sellers Clap Back At Critiques, Flag Insider Trade Data

Benzinga - by Adam Eckert, Benzinga Staff Writer.

Palantir Technologies Inc (NYSE:PLTR) CEO Alex Karp slammed short sellers this week, claiming that short sellers have cocaine habits. Some big-time short sellers were quick to respond.

“I love burning the short sellers. Almost nothing makes a human happier than taking the lines of cocaine away from these short sellers, who, like, are going short on a truly great American company,” Karp said Wednesday in an interview aired on CNBC’s “Money Movers.”

“They just love pulling down great American companies so they can pay for their coke,” Karp added. “The best thing that can happen to them is we will provide, we will lead their coke dealers to their homes after they can’t pay their bills … Do your thing, we’ll do our thing.”

Check This Out: ‘Not Just Ours’ – Palantir CEO Says Short Sellers ‘Love Pulling Down Great American Companies So They Can Pay For Their Coke’

Short Sellers Fire Back: Some prominent short sellers took to social media to respond to Karp’s fiery comments.

Kynikos Associates founder and famed short seller Jim Chanos pointed out that it’s insiders who have been selling stock.

“In the LTM short-sellers have bought(!) 60M shares, net, of $PLTR shares. Insiders have been selling,” Chanos said in an X post.

The legendary shortseller highlighted recent sales from insiders in the post and specifically pointed to co-founder Peter Thiel’s stock sale from Tuesday. According to Benzinga’s Insider data, Thiel sold 7.045 million shares at an average price of $24.79, however the sale was part of a Rule 10b5-1 trading plan.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bronte Capital Management’s John Hempton also took to X to respond to Karp’s comments. He noted that he runs one of the “biggest short selling books in the world” and said he has never snorted cocaine.

Instead, he suggested that Karp may be projecting his own negative traits on others.

“My guess is projection — but not hanging around cocaine snorting parties, I have never seen Alex Karp snorting cocaine,” Hempton said.

Palantir shares have rallied more than 200% over a one-year period, largely driven by the company’s positioning in the AI space. Some market pundits have begun throwing the “bubble” word around as several companies have seen share prices soar on the back of AI. However, Palantir has now met or exceeded analyst expectations in five straight quarters, according to Benzinga Pro.

PLTR Price Action: Palantir shares are up about 41% year-to-date. The stock was down 2.66% at $24.36 at the time of writing, according to Benzinga Pro.

Image created with Midjourney and a photo from Kondor83/Shutterstock.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.